1. P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. (25th January 2019) Authors: Ungaro, R; Fenster, M; Dimopoulos, C; Patel, A; Deepak, P; Syal, G; Yarur, A; Hirten, R; Christophi, G; Khatiwada, A; Lin, B; Colombel, J-F; Ha, C; Weisshof, R; Beniwal-Patel, P; Cohen, B; Pekow, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study. (25th January 2019) Authors: Yarur, A; Bixuan, L; Deepak, P; Khatiwada, A; Christophi, G; Ciorba, M; Ungaro, R; Fenster, M; Dimopoulos, C; Syal, G; Hirten, R; Colombel, J-F; Ha, C; Weisshof, R; Pekow, J; Patel, A; Beniwal-Patel, P; Cohen, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP40 Efficacy of risankizumab induction and maintenance therapy by baseline Crohn's Disease location: Post hoc analysis of the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. (21st January 2022) Authors: Bossuyt, P; Bresso, F; Dubinsky, M; Ha, C; Siegel, C; Zambrano, J; Kligys, K; Kalabic, J; Zhang, Y; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P260 An analysis of non-melanoma skin cancer rates in the tofacitinib Ulcerative Colitis clinical programme. (27th May 2021) Authors: Sands, B E; Cohen, R D; Ha, C; Reinisch, W; Salese, L; Mundayat, R; Lawendy, N; Panés, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The French Musculoskeletal Disorders Surveillance Program: Pays de la Loire network. Issue 7 (5th March 2009) Authors: Ha, C; Roquelaure, Y; Leclerc, A; Touranchet, A; Goldberg, M; Imbernon, E Journal: Occupational and environmental medicine Issue: Volume 66:Issue 7(2009) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Why are manual workers at high risk of upper limb disorders? The role of physical work factors in a random sample of workers in France (the Pays de la Loire study). Issue 11 (20th June 2006) Authors: Melchior, M; Roquelaure, Y; Evanoff, B; Chastang, J-F; Ha, C; Imbernon, E; Goldberg, M; Leclerc, A Other Names: group-author. Journal: Occupational and environmental medicine Issue: Volume 63:Issue 11(2006) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Background study of NaI(Tl) crystals for the KIMS-NaI experiment. Issue 4 (May 2016) Authors: Adhikari, P; Adhikari, G; Choi, S; Ha, C; Hahn, I S; Jeon, EJ; Joo, H W; Kang, W G; Kim, H J; Kim, H O; Kim, K W; Kim, N Y; Kim, S K; Kim, Y D; Kim, Y H; Lee, H S; Lee, J H; Lee, M H; Leonard, D S; Li, J Journal: Journal of physics Issue: Volume 718:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P550 Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years. (30th January 2023) Authors: Taxonera, C; Ha, C; del Pilar Fortes, M; Gardiner, S; Mundayat, R; Ghosh, S; Connor, S J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease. (30th January 2023) Authors: Bettenworth, D; Baker, M E; Bemelmann, W; Bruining, D; D'Haens, G; D'Hoore, A; Dignass, A; Dotan, I; Feagan, B G; Feakins, R; Fleshner, P; Fletcher, J G; Gordon, I; Ha, C; Gaylyn, H; Jairath, V; Lu, C; Lyu, R; Ng, S C; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P379 Effect of upadacitinib on inflammatory markers and clinical outcomes in patients with Crohn's disease in the phase 3, U-EXCEL, U-EXCEED, and U-ENDURE studies. (30th January 2023) Authors: Vermeire, S; Danese, S; Cohen, B L; Magro, F; Chen, Y; Ha, C; Dubcenco, E; Lacerda, A P; Marced, E; Oomen, J; Garrison, A; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗